Specificity of glycosaminoglycan suppression of endothelin-1 production by human umbilical vein endothelial cells

被引:1
作者
Valencia, AO [1 ]
Mileva, MM [1 ]
Dweck, HS [1 ]
Rosenfeld, L [1 ]
机构
[1] New York Med Coll, Dept Pediat, Div Neonatol, Neonatal Res Lab,Westchester Cty Med Ctr, Valhalla, NY 10595 USA
关键词
endothelin-1; glycosaminoglycan; human umbilical vein endothelial cells;
D O I
10.1016/S0024-3205(99)00246-5
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Endothelin-1 (ET-1) is the most potent vasoconstrictor peptide found in nature. Its production is stimulated by thrombin. By inhibiting thrombin we have previously shown that heparin, a highly negatively-charged glycosaminoglycan (GAG), suppresses the production of ET-1 by cultured human umbilical vein endothelial cells (HUVEC). The purpose of our study is to determine the effect of other GAGS and related compounds on ET-1 production. The GAGs and related compounds used in the study were: chondroitin sulfate A, chondroitin sulfate B, chondroitin sulfate C, fucoidin, low molecular weight dextran sulfate, high molecular weight dextran sulfate, and hyaluronan. HUVEC were incubated for 48 hr with media containing these GAGs and related compounds and with media without GAG as control. ET-1 levels were measured by radioimmunoassay. GAGs and related molecules with higher sulfate content, heparin, chondroitin sulfate B, low and high molecular weight dextran sulfates significantly suppressed ET-1 production by HUVEC. Fucoidin also suppressed ET-1 production despite its lower sulfate content, probably because of its structural similarity to heparin. These compounds may be useful for future in vivo studies.
引用
收藏
页码:279 / 284
页数:6
相关论文
共 48 条
[1]   CLONING AND EXPRESSION OF A CDNA-ENCODING AN ENDOTHELIN RECEPTOR [J].
ARAI, H ;
HORI, S ;
ARAMORI, I ;
OHKUBO, H ;
NAKANISHI, S .
NATURE, 1990, 348 (6303) :730-732
[2]   Endothelin-1 causes a prolonged protein kinase C activation and acts as a co-mitogen in vascular smooth muscle cells [J].
Assender, JW ;
Irenius, E ;
Fredholm, BB .
ACTA PHYSIOLOGICA SCANDINAVICA, 1996, 157 (04) :451-460
[3]   RELEASE OF ENDOTHELIN FROM THE PORCINE AORTA - INHIBITION BY ENDOTHELIUM-DERIVED NITRIC-OXIDE [J].
BOULANGER, C ;
LUSCHER, TF .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (02) :587-590
[4]   Endothelin-1: A scientist's curiosity, or a real player in ischemic heart disease? [J].
Cesari, M ;
Pavan, E ;
Sacchetto, A ;
Rossi, GP .
AMERICAN HEART JOURNAL, 1996, 132 (06) :1236-1243
[5]   PATHOPHYSIOLOGICAL ROLE OF ENDOTHELIN REVEALED BY THE 1ST ORALLY-ACTIVE ENDOTHELIN RECEPTOR ANTAGONIST [J].
CLOZEL, M ;
BREU, V ;
BURRI, K ;
CASSAL, JM ;
FISCHLI, W ;
GRAY, GA ;
HIRTH, G ;
LOFFLER, BM ;
MULLER, M ;
NEIDHART, W ;
RAMUZ, H .
NATURE, 1993, 365 (6448) :759-761
[6]   EVIDENCE FOR AN EFFECTOR ROLE OF ENDOTHELIN IN CLOSURE OF THE DUCTUS-ARTERIOSUS AT BIRTH [J].
COCEANI, F ;
KELSEY, L ;
SEIDLITZ, E .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1992, 70 (07) :1061-1064
[7]   STRUCTURE AND FUNCTION OF HEPARAN-SULFATE PROTEOGLYCANS [J].
GALLAGHER, JT ;
LYON, M ;
STEWARD, WP .
BIOCHEMICAL JOURNAL, 1986, 236 (02) :313-325
[8]  
GLABE CG, 1983, J CELL SCI, V61, P475
[9]  
GOETZ KL, 1989, AM J PHYSIOL, V16, P235
[10]   Is endothelin-1 a mediator in asthma? [J].
Hay, DWP ;
Henry, PJ ;
Goldie, RG .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 154 (06) :1594-1597